A, W., G, S., D, R., G, C., S, D. Y., A, M., . . . F, M. (2024). Disease Trajectories in the Revised Hammersmith Scale in a Cohort of Untreated Patients with Spinal Muscular Atrophy types 2 and 3. Journal of neuromuscular diseases, 11(3), 665. https://doi.org/10.3233/JND-230211
Chicago Style (17th ed.) CitationA, Wolfe, et al. "Disease Trajectories in the Revised Hammersmith Scale in a Cohort of Untreated Patients with Spinal Muscular Atrophy Types 2 and 3." Journal of Neuromuscular Diseases 11, no. 3 (2024): 665. https://doi.org/10.3233/JND-230211.
MLA (9th ed.) CitationA, Wolfe, et al. "Disease Trajectories in the Revised Hammersmith Scale in a Cohort of Untreated Patients with Spinal Muscular Atrophy Types 2 and 3." Journal of Neuromuscular Diseases, vol. 11, no. 3, 2024, p. 665, https://doi.org/10.3233/JND-230211.